Once touted as a COVID-19 'game changer,' Paxlovid is now a

Early trials showed Paxlovid could be a 'game changer' to keep people out of hospital. Yet the COVID-19 landscape has changed since then, with most people now protected against serious illness thanks to vaccination or past infections. So who should get the Pfizer antiviral going forward?

Related Keywords

Toronto , Ontario , Canada , Ottawa , Canadians , Canadian , Cole Burston , Lynora Saxinger , Hilda Reder , Justin Morgenstern , Iris Gorfinkel , Shelita Dattani , Linda Pauderis , Josh Matlow , University Of Toronto , Sinai Health System , Health Second Opinion , Pfizer , University Of Alberta , Neighbourhood Pharmacy Association Of Canada , National Institutes Of Health , Public Health Agency Of Canada , Second Opinion , Nathan Stall , Canadian Press , Nova Scotia , Jennifer Lush , Neighbourhood Pharmacy Association , National Institutes , Public Health Agency ,